Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for ...
The sellers in the transaction include a group of entities, with the most notable being Senoti Properties, a joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback